This study investigated mortality and causes of death between 1988 and 1999 in 14 781 persons (6702 female) with Down syndrome in California, comparing age, sex, ethnicity, and other factors. Mean age at the start of follow-up was 14 years 8 months (SD 14y 10mo). During the study period 600 persons died. The standardized mortality ratio (SMR) for the population was 5.5. Blacks were at greater risk than whites, Hispanics, or Asians (relative risk=1.5). Mortality declined during the period, especially for children with congenital heart defects. Leukemia (SMR=17), respiratory illnesses (SMR=27), congenital anomalies (SMR=72), and circulatory diseases (SMR=5.3) accounted for most of the excess mortality. With the exception of leukemia, cancer m...
Background: Late health consequences of treatment for childhood leukemia are well documented. Althou...
Background: Down syndrome (DS) affects 1 per 650–1000 live births and is the most common known genet...
To assess the impact of congenital malformations in Down syndrome (DS) on morbidity, mortality and o...
Background: It is thought that people with Down syndrome die younger than the general population, b...
Background: It is thought that people with Down syndrome die younger than the general population, ...
A cohort study of 1425 persons with Down's syndrome (DS), and of their parents (447 mothers, 435 fat...
International audienceCancer in Down syndrome (DS) is characterized by a well known and marked exces...
SUMMARY Mortality in sufferers from Down's syndrome over the age of 1 year in the 1970s was ana...
Adults with Down syndrome often die at earlier ages than their peers in the general population. This...
Abstract: Cancer in Down syndrome (DS) is characterized by a well known and marked excess of leukemi...
Objectives: To describe the mortality patterns, comorbidities, and attendance at accident and emer...
Objectives To investigate mortality in adults with intellectual disabilities: rates, causes, place, ...
BackgroundThe prevalence of Down syndrome (DS)-affected births has increased during the past 30 year...
Objectives: To investigate mortality in adults with intellectual disabilities: rates, causes, place,...
Abstract: A case of a woman who is among the longest surviving people with Down Syndrome was describ...
Background: Late health consequences of treatment for childhood leukemia are well documented. Althou...
Background: Down syndrome (DS) affects 1 per 650–1000 live births and is the most common known genet...
To assess the impact of congenital malformations in Down syndrome (DS) on morbidity, mortality and o...
Background: It is thought that people with Down syndrome die younger than the general population, b...
Background: It is thought that people with Down syndrome die younger than the general population, ...
A cohort study of 1425 persons with Down's syndrome (DS), and of their parents (447 mothers, 435 fat...
International audienceCancer in Down syndrome (DS) is characterized by a well known and marked exces...
SUMMARY Mortality in sufferers from Down's syndrome over the age of 1 year in the 1970s was ana...
Adults with Down syndrome often die at earlier ages than their peers in the general population. This...
Abstract: Cancer in Down syndrome (DS) is characterized by a well known and marked excess of leukemi...
Objectives: To describe the mortality patterns, comorbidities, and attendance at accident and emer...
Objectives To investigate mortality in adults with intellectual disabilities: rates, causes, place, ...
BackgroundThe prevalence of Down syndrome (DS)-affected births has increased during the past 30 year...
Objectives: To investigate mortality in adults with intellectual disabilities: rates, causes, place,...
Abstract: A case of a woman who is among the longest surviving people with Down Syndrome was describ...
Background: Late health consequences of treatment for childhood leukemia are well documented. Althou...
Background: Down syndrome (DS) affects 1 per 650–1000 live births and is the most common known genet...
To assess the impact of congenital malformations in Down syndrome (DS) on morbidity, mortality and o...